Janus Henderson Group PLC Corcept Therapeutics Inc Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 341,810 shares of CORT stock, worth $19.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

341,810

Previous 265,049 28.96%

Holding current value

$19.8 Million

Previous $6.68 Million 66.34%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $1.7 Million - $2.65 Million	76,761 Added 28.96%	341,810 $11.1 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $4.63 Million - $6.03 Million	219,551 Added 482.55%	265,049 $6.68 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $1,712 - $2,268	-69 Reduced 0.15%	45,498 $1.48 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $461 - $709	21 Added 0.05%	45,567 $1.24 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $1.72 Million - $2.02 Million	-80,254 Reduced 63.79%	45,546 $1.01 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $326,688 - $416,357	-17,015 Reduced 11.91%	125,800 $2.72 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $5.67 Million - $8.52 Million	-284,348 Reduced 66.57%	142,815 $2.9 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $6.78 Million - $8 Million	274,652 Added 180.09%	427,163 $11 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $402,870 - $588,149	23,247 Added 17.98%	152,511 $3.63 Million
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $782,315 - $1.19 Million	-47,327 Reduced 26.8%	129,264 $2.91 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $260,757 - $355,911	15,249 Added 9.45%	176,591 $3.5 Million
Q3 2021 Nov 16, 2021	SELL	$19.68 - $22.53 $595,831 - $682,118	-30,276 Reduced 15.8%	161,342 $3.18 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $573,937 - $702,118	-28,740 Reduced 13.04%	191,618 $4.22 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $1.87 Million - $2.44 Million	79,693 Added 56.65%	220,358 $5.24 Million
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $351,171 - $571,334	20,928 Added 17.48%	140,665 $3.68 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $269,659 - $432,407	21,642 Added 22.06%	119,737 $2.08 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $860,255 - $1.43 Million	78,205 Added 393.19%	98,095 $1.65 Million
Q1 2020 May 14, 2020	SELL	$10.11 - $14.04 $469,447 - $651,933	-46,434 Reduced 70.01%	19,890 $236,000
Q4 2019 Feb 18, 2020	BUY	$12.06 - $16.96 $45,321 - $63,735	3,758 Added 6.01%	66,324 $803,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $81,968 - $115,432	7,874 Added 14.4%	62,566 $884,000
Q2 2019 Jul 31, 2019	SELL	$9.78 - $12.76 $12,958 - $16,907	-1,325 Reduced 2.37%	54,692 $610,000
Q1 2019 Apr 30, 2019	BUY	$10.03 - $15.71 $561,850 - $880,027	56,017 New	56,017 $658,000

Others Institutions Holding CORT

# of Institutions

337

Shares Held

87.5M

Call Options Held

1.08M

Put Options Held

852K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.19B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Corcept Therapeutics Inc Transaction History